Summary
- Current Price
- As of today, MIRM price is $98.30, up +4.69% in the most recent trading session on
- Current Price All-Time High
- MIRM price is currently -24.38% below its historical high of $130.00 set on
- Market Cap
- MIRM current market cap is $6B, up +72.80% over the past 365 days
- Revenue
- MIRM current annual revenue is $521.31M, up +54.74% year-over-year
- Next Earnings
- The next earnings release for MIRM is on
Profile
| Metric | Value |
|---|---|
| Full Name | Mirum Pharmaceuticals, Inc. |
| Ticker | NASDAQ: MIRM |
| Exchange | NASDAQ |
| Sector | Healthcare |
| Industry | Biotechnology |
| Country | United States |
| IPO | |
| Indexes | Not included |
| Website | mirumpharma.com |
| Employees | 334 |
Key Metrics
| Metric | Value | Date |
|---|---|---|
| Price | $98.30 | |
| Price, 1D Change | +4.69% | |
| $6B | ||
| - | ||
| - | ||
| 0.97 | ||
| $521.31M | ||
| Revenue, 1Y Change | +54.74% | |
| -$0.47 | ||
| EPS, 1Y Change | +74.85% |
Chart
SUGGESTED SERIES
Events
| Metric | Value | Date |
|---|---|---|
| Next Earnings | ||
| Last Qtr. Earnings | ||
| Last Ann. Earnings | ||
| Last Ex-Dividend | N/A | N/A |
| Next Ex-Dividend | N/A | N/A |
| Last Split | N/A | N/A |
| Next Split | N/A | N/A |
| Last Ticker Change | N/A | N/A |
| Next Ticker Change | N/A | N/A |
🔒 Log In To Unlock Full Data
Estimates
| Metric | Value | Date |
|---|---|---|
| -$0.47 | ||
| EPS Estimate | -$15.14 | N/A |
| EPS Est. Change | -3,153.12% | N/A |
| $521.31M | ||
| Revenue Estimate | $696.58M | N/A |
| Revenue Est. Change | +33.62% | N/A |
| Current Price | $98.30 | |
| Price Target | $137.00 | - |
| Price Tgt. Change | +39.37% | - |
🔒 Log In To Unlock Full Data
EPS
| Year | Estimate | Reported | Surprise / Exp. |
|---|---|---|---|
| -$1.42 | -$1.85 | -30.13% | |
| -$0.26 | -$0.47 | -76.02% | |
| -$15.14 | N/A | -3,153.12% | |
| -$0.35 | N/A | +25.50% |
Revenue
| Year | Estimate | Reported | Surprise / Exp. |
|---|---|---|---|
| $334.50M | $336.89M | +0.71% | |
| $515.52M | $521.31M | +1.12% | |
| $696.58M | N/A | +33.62% | |
| $815.98M | N/A | +56.52% |
🔒 Log In To Unlock Full Data
Performance
Technicals
| Metric | Value | Date |
|---|---|---|
| Current Price | $98.30 | |
| $96.86 | ||
| $106.17 | ||
| $95.32 | ||
| $102.36 | ||
| -$1.86 | ||
| 0.97 | ||
| $3.96 | ||
| 36.28 | ||
| 27.44% |
Dividends
| Metric | Value | Date |
|---|---|---|
| - | N/A | |
| Upcoming | N/A | N/A |
| - | ||
| - | ||
| $0.00 | ||
| 0.00% |
🔒 Log In To Unlock Full Data
Income & Profitability
| Metric | Value | Date |
|---|---|---|
| $521.31M | ||
| -$0.47 | ||
| $420.73M | ||
| 80.71% | ||
| -$22.14M | ||
| -4.25% | ||
| -$23.36M | ||
| -4.48% | ||
| $2.11M |
🔒 Log In To Unlock Full Data
Financial Health
| Metric | Value | Date |
|---|---|---|
| 1.02 | ||
| 2.67 | ||
| 2.55 | ||
| - | ||
| 3 | ||
| 7.16 |
Valuations
| Metric | Value | Date |
|---|---|---|
| - | ||
| 10.33 | ||
| -612.42 | ||
| -102.74 | ||
| - | N/A |
Balance Sheet
| Metric | Value | Date |
|---|---|---|
| $314.69M | ||
| $383.33M | ||
| $842.81M | ||
| $549.68M | ||
| $528.12M | ||
| $205.80M | ||
| $319.45M | ||
| $2.14M | ||
| $9.61M |
Expenses
| Metric | Value | Date |
|---|---|---|
| $544.68M | ||
| $442.86M | ||
| $100.58M | ||
| $0.00 | ||
| $24.24M | ||
| $0.00 | ||
| $1.94M |
Cash Flow
| Metric | Value | Date |
|---|---|---|
| $55.83M | ||
| -$23.95M | ||
| $40.14M | ||
| $954.00K | ||
| $54.87M |
Recent analyst updates
| Metric | Value | Date |
|---|---|---|
| Citizens | → | |
| TD Cowen | → | |
| RBC Capital | → | |
| HC Wainwright & Co. | → | |
| Citizens | → | |
| RBC Capital | → | |
| JP Morgan | → | |
| Citizens | → | |
| Morgan Stanley | → | |
| Citigroup |
Analyst sentiment
Institutional ownership
No data
Screeners with MIRM
FAQ
- What is the ticker symbol for Mirum Pharmaceuticals, Inc.?
- The ticker symbol for Mirum Pharmaceuticals, Inc. is NASDAQ:MIRM
- Does Mirum Pharmaceuticals, Inc. pay dividends?
- No, Mirum Pharmaceuticals, Inc. does not pay dividends
- What sector is Mirum Pharmaceuticals, Inc. in?
- Mirum Pharmaceuticals, Inc. is in the Healthcare sector
- What industry is Mirum Pharmaceuticals, Inc. in?
- Mirum Pharmaceuticals, Inc. is in the Biotechnology industry
- What country is Mirum Pharmaceuticals, Inc. based in?
- Mirum Pharmaceuticals, Inc. is headquartered in United States
- When did Mirum Pharmaceuticals, Inc. go public?
- Mirum Pharmaceuticals, Inc. initial public offering (IPO) was on July 18, 2019
- Is Mirum Pharmaceuticals, Inc. in the S&P 500?
- No, Mirum Pharmaceuticals, Inc. is not included in the S&P 500 index
- Is Mirum Pharmaceuticals, Inc. in the NASDAQ 100?
- No, Mirum Pharmaceuticals, Inc. is not included in the NASDAQ 100 index
- Is Mirum Pharmaceuticals, Inc. in the Dow Jones?
- No, Mirum Pharmaceuticals, Inc. is not included in the Dow Jones index
- When was Mirum Pharmaceuticals, Inc. last earnings report?
- Mirum Pharmaceuticals, Inc.'s most recent earnings report was on August 5, 2026
- When does Mirum Pharmaceuticals, Inc. report earnings?
- The next expected earnings date for Mirum Pharmaceuticals, Inc. is November 4, 2026
Data Sources & References
- MIRM Official Website www.mirumpharma.com
- Most Recent Annual Report (10-K) www.sec.gov/Archives/edgar/data/1759425/000175942526000013/0001759425-26-000013-index.htm
- MIRM Profile on Yahoo Finance finance.yahoo.com/quote/MIRM
- MIRM Profile on NASDAQ.com www.nasdaq.com/market-activity/stocks/mirm